Maturation of human cardiac organoids enables complex disease modeling and drug discovery
Open Access
- 25 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Cardiovascular Research
- Vol. 4 (7) , 821-840
Abstract
Maturation of human pluripotent stem (hPS) cell-derived cardiomyocytes is critical for their use as a model system. Here we mimic human heart maturation pathways in the setting of hPS cell-derived cardiac organoids (hCOs). Specifically, transient activation of 5′ AMP-activated protein kinase and estrogen-related receptor enhanced cardiomyocyte maturation, inducing expression of mature sarcomeric and oxidative phosphorylation proteins, and increasing metabolic capacity. hCOs generated using the directed maturation protocol (DM-hCOs) recapitulate cardiac drug responses and, when derived from calsequestrin 2 (CASQ2) and ryanodine receptor 2 (RYR2) mutant hPS cells exhibit a pro-arrhythmia phenotype. These DM-hCOs also comprise multiple cell types, which we characterize and benchmark to the human heart. Modeling of cardiomyopathy caused by a desmoplakin (DSP) mutation resulted in fibrosis and cardiac dysfunction and led to identifying the bromodomain and extra-terminal inhibitor INCB054329 as a drug mitigating the desmoplakin-related functional defect. These findings establish DM-hCOs as a versatile platform for applications in cardiac biology, disease and drug screening.Keywords
This publication has 92 references indexed in Scilit:
- Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular TachycardiaCirculation, 2002
- Sinoatrial Nodal Cell Ryanodine Receptor and Na + -Ca 2+ ExchangerCirculation Research, 2001
- Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.Journal of Clinical Investigation, 1996
- The role of the sarcoplasmic reticulum in various types of cardiomyocytesMolecular and Cellular Biochemistry, 1994
- Different β‐adrenoceptor‐effector coupling in human ventricular and atrial myocardiumEuropean Journal of Clinical Investigation, 1991
- Negative Inotropic Properties of Isradipine, Nifedipine, Diltiazem, and Verapamil in Diseased Human Myocardial TissueJournal of Cardiovascular Pharmacology, 1990
- Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heartJournal of Molecular Medicine, 1988
- Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardiumNaunyn-Schmiedeberg's Archives of Pharmacology, 1988
- Concentration-response curves of positive inotropic agents before and after ouabain pretreatmentCardiovascular Research, 1985
- Ryanodine alteration of the contractile state of rat ventricular myocardium. Comparison with dog, cat, and rabbit ventricular tissues.Circulation Research, 1980